These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 17935988)
1. Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. 5. Opioid receptor binding properties of N-((4'-phenyl)-phenethyl) analogues of 8-CAC. VanAlstine MA; Wentland MP; Cohen DJ; Bidlack JM Bioorg Med Chem Lett; 2007 Dec; 17(23):6516-20. PubMed ID: 17935988 [TBL] [Abstract][Full Text] [Related]
2. Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. 4. Opioid receptor binding properties of 8-[N-(4'-phenyl)-phenethyl)carboxamido] analogues of cyclazocine and ethylketocycalzocine. Wentland MP; VanAlstine M; Kucejko R; Lou R; Cohen DJ; Parkhill AL; Bidlack JM J Med Chem; 2006 Sep; 49(18):5635-9. PubMed ID: 16942039 [TBL] [Abstract][Full Text] [Related]
3. Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. Part 6: Opioid receptor binding properties of cyclic variants of 8-carboxamidocyclazocine. Wentland MP; Sun X; Cohen DJ; Bidlack JM Bioorg Med Chem; 2008 May; 16(10):5653-64. PubMed ID: 18417347 [TBL] [Abstract][Full Text] [Related]
4. Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. Part 7: syntheses and opioid receptor properties of cyclic variants of cyclazocine. Wentland MP; Lu Q; Ganorkar R; Zhang SZ; Jo S; Cohen DJ; Bidlack JM Bioorg Med Chem Lett; 2009 Jan; 19(2):365-8. PubMed ID: 19091564 [TBL] [Abstract][Full Text] [Related]
5. Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. Part 8. High affinity ligands for opioid receptors in the picomolar Ki range: oxygenated N-(2-[1,1'-biphenyl]-4-ylethyl) analogues of 8-CAC. Wentland MP; Jo S; Gargano JM; VanAlstine MA; Cohen DJ; Bidlack JM Bioorg Med Chem Lett; 2012 Dec; 22(24):7340-4. PubMed ID: 23142613 [TBL] [Abstract][Full Text] [Related]
6. 8-Carboxamidocyclazocine analogues: redefining the structure-activity relationships of 2,6-methano-3-benzazocines. Wentland MP; Lou R; Ye Y; Cohen DJ; Richardson GP; Bidlack JM Bioorg Med Chem Lett; 2001 Mar; 11(5):623-6. PubMed ID: 11266156 [TBL] [Abstract][Full Text] [Related]
7. Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. Part 2: 8-formamidocyclazocine analogues. Wentland MP; Sun X; Ye Y; Lou R; Bidlack JM Bioorg Med Chem Lett; 2003 Jun; 13(11):1911-4. PubMed ID: 12749896 [TBL] [Abstract][Full Text] [Related]
8. Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. Part 3: 8-Thiocarboxamido and 8-thioformamido derivatives of cyclazocine. Wentland MP; Sun X; Bu Y; Lou R; Cohen DJ; Bidlack JM Bioorg Med Chem Lett; 2005 May; 15(10):2547-51. PubMed ID: 15863314 [TBL] [Abstract][Full Text] [Related]
9. Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. Part 9: Synthesis, characterization and molecular modeling of pyridinyl isosteres of N-BPE-8-CAC (1), a high affinity ligand for opioid receptors. VanAlstine MA; Wentland MP; Alvarez J; Cao Q; Cohen DJ; Knapp BI; Bidlack JM Bioorg Med Chem Lett; 2013 Apr; 23(7):2128-33. PubMed ID: 23434225 [TBL] [Abstract][Full Text] [Related]
11. Synthesis of (+)-(1'R,2'S) and (1'S,2'R)-6,11-dimethyl-1,2,3,4,5,6 -hexahydro-3-[[2'-(alkoxycarbonyl)-2'-phenylcyclopropyl]methyl]-2 ,6 -methano-3-benzazocin-8-ol. Comparison of the affinities for sigma 1 and opioid receptors with in the diastereoisomeric MPCB and CCB. Ronsisvalle G; Prezzavento O; Pasquinucci L; Pappalardo MS; Marrazzo A; Vittorio F; Carboni L; Spampinato S Farmaco; 1997; 52(6-7):471-6. PubMed ID: 9372600 [TBL] [Abstract][Full Text] [Related]
12. Syntheses and opioid receptor binding affinities of 8-amino-2,6-methano-3-benzazocines. Wentland MP; Ye Y; Cioffi CL; Lou R; Zhou Q; Xu G; Duan W; Dehnhardt CM; Sun X; Cohen DJ; Bidlack JM J Med Chem; 2003 Feb; 46(5):838-49. PubMed ID: 12593663 [TBL] [Abstract][Full Text] [Related]
13. 8-Aminocyclazocine analogues: synthesis and structure-activity relationships. Wentland MP; Xu G; Cioffi CL; Ye Y; Duan W; Cohen DJ; Colasurdo AM; Bidlack JM Bioorg Med Chem Lett; 2000 Jan; 10(2):183-7. PubMed ID: 10673107 [TBL] [Abstract][Full Text] [Related]
19. Antipodal alpha-N-(methyl through decyl)-N-normetazocines (5,9 alpha-dimethyl-2'-hydroxy-6,7-benzomorphans): in vitro and in vivo properties. May EL; Aceto MD; Bowman ER; Bentley C; Martin BR; Harris LS; Medzihradsky F; Mattson MV; Jacobson AE J Med Chem; 1994 Sep; 37(20):3408-18. PubMed ID: 7932569 [TBL] [Abstract][Full Text] [Related]
20. Affinity of the enantiomers of alpha- and beta-cyclazocine for binding to the phencyclidine and mu opioid receptors. Todd SL; Balster RL; Martin BR Life Sci; 1990; 46(12):895-901. PubMed ID: 2157122 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]